Chinatrust Financial Holdings Co (中國信託金控) signed an underwriting agreement with ScinoPharm Taiwan Ltd (台灣神隆) yesterday, paving the way for the biotech company to become listed on Taiwan's over-the-counter stock exchange -- the TAISDAQ (櫃買中心).
ScinoPharm, the largest independent US Food & Drug Administration-approved biotechnology company in Asia, plans to go public in the fourth quarter of 2004, with stocks trading unofficially from as early as February next year.
A Chinatrust official is optimistic over the biotech venture's prospects.
"ScinoPharm is developing drugs to treat strokes, heart problems and cancer," Michael Jong (
"It's a fascinating industry. Just look at the example of Viagra and how popular it is," he said.
ScinoPharm makes pharmaceutical products for other companies and specializes in active pharmaceutical ingredients (APIs).
The most expensive part of a drug, APIs are the actual medicinal content.
Biotechnology has now been recognized as a sub-sector of the TAISDAQ. Ten companies are already listed in the sub-sector.
Chinatrust's support of ScinoPharm is an indication of growing interest in the pharmaceutical industry.
"ScinoPharm is the first biotechnology company we are underwriting," Jong said.
According to one market observer, an underwriting agreement shows confidence in a company, but it does not involve putting cash up front.
"The underwriter, generally speaking, agrees to purchase stock at a heavy discount and then sell it on to brokers," said David Silver, director of BiotechEast, a Web site that promotes Taiwan's biotechnology and pharmaceutical industries.
Whatever stock they do not sell on, they are obliged to buy themselves, he said.
Although Chinatrust Securities does not yet have any plans to invest in ScinoPharm, the agreement demonstrates a long-term commitment, Jong said.
"With biotechnology companies you have to invest for the long term -- five to 10 years -- before you see any return," he said. "It's not like the computer industry," he said.
But the market might not have to wait that long. ScinoPharm is already producing drugs for a large US pharmaceutical company.
"We had our first commercial launch two months ago," Jo Shen (馬海怡), ScinoPharm's president and CEO, said after the signing ceremony yesterday. "We hope to launch new products every few months from now on. We are working with a lot of multinational firms in the sector."
Shen brushed aside recent concerns raised over competition from other Asian countries, such as India and China, where labor costs are cheaper.
"India and China are our allies, not our competitors," Shen said. "They provide raw materials for us, but they lack compliance with FDA regulations and patent protection, so they cannot compete."
The Taiwan government is actively promoting biotechnology and has pledged NT$52 billion to the industry over the next five years.
Part of this investment includes low rents on facilities in industrial areas dedicated to biotechnology.
The first of these is inside the new Tainan Science-based Industrial Park (
DECOUPLING? In a sign of deeper US-China technology decoupling, Apple has held initial talks about using Baidu’s generative AI technology in its iPhones, the Wall Street Journal said China has introduced guidelines to phase out US microprocessors from Intel Corp and Advanced Micro Devices Inc (AMD) from government PCs and servers, the Financial Times reported yesterday. The procurement guidance also seeks to sideline Microsoft Corp’s Windows operating system and foreign-made database software in favor of domestic options, the report said. Chinese officials have begun following the guidelines, which were unveiled in December last year, the report said. They order government agencies above the township level to include criteria requiring “safe and reliable” processors and operating systems when making purchases, the newspaper said. The US has been aiming to boost domestic semiconductor
Nvidia Corp earned its US$2.2 trillion market cap by producing artificial intelligence (AI) chips that have become the lifeblood powering the new era of generative AI developers from start-ups to Microsoft Corp, OpenAI and Google parent Alphabet Inc. Almost as important to its hardware is the company’s nearly 20 years’ worth of computer code, which helps make competition with the company nearly impossible. More than 4 million global developers rely on Nvidia’s CUDA software platform to build AI and other apps. Now a coalition of tech companies that includes Qualcomm Inc, Google and Intel Corp plans to loosen Nvidia’s chokehold by going
ENERGY IMPACT: The electricity rate hike is expected to add about NT$4 billion to TSMC’s electricity bill a year and cut its annual earnings per share by about NT$0.154 Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) has left its long-term gross margin target unchanged despite the government deciding on Friday to raise electricity rates. One of the heaviest power consuming manufacturers in Taiwan, TSMC said it always respects the government’s energy policy and would continue to operate its fabs by making efforts in energy conservation. The chipmaker said it has left a long-term goal of more than 53 percent in gross margin unchanged. The Ministry of Economic Affairs concluded a power rate evaluation meeting on Friday, announcing electricity tariffs would go up by 11 percent on average to about NT$3.4518 per kilowatt-hour (kWh)
OPENING ADDRESS: The CEO is to give a speech on the future of high-performance computing and artificial intelligence at the trade show’s opening on June 3, TAITRA said Advanced Micro Devices Inc (AMD) chairperson and chief executive officer Lisa Su (蘇姿丰) is to deliver the opening keynote speech at Computex Taipei this year, the event’s organizer said in a statement yesterday. Su is to give a speech on the future of high-performance computing (HPC) in the artificial intelligence (AI) era to open Computex, one of the world’s largest computer and technology trade events, at 9:30am on June 3, the Taiwan External Trade Development Council (TAITRA) said. Su is to explore how AMD and the company’s strategic technology partners are pushing the limits of AI and HPC, from data centers to